The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[(2(S)-Azetidinyl)methoxy]-5-[(1S,2R)-2-[2-(Ncyclopropylcarbamoyloxy)ethyl]cyclopropyl]-pyridine ID: ALA2024091
PubChem CID: 56951372
Max Phase: Preclinical
Molecular Formula: C18H25N3O3
Molecular Weight: 331.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1CC1)OCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
Standard InChI: InChI=1S/C18H25N3O3/c22-18(21-14-1-2-14)23-6-4-12-8-17(12)13-7-16(10-19-9-13)24-11-15-3-5-20-15/h7,9-10,12,14-15,17,20H,1-6,8,11H2,(H,21,22)/t12-,15-,17-/m0/s1
Standard InChI Key: YPUPVMYOUBYNAY-NUTKFTJISA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
7.7703 -7.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5356 -7.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4205 -6.7820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6278 -7.7124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6266 -8.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3414 -8.9527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0579 -8.5393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0550 -7.7088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3396 -7.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9132 -7.3001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1988 -7.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4843 -7.3004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2661 -6.5006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4692 -6.7144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6829 -7.5112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1969 -7.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9129 -7.6980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6258 -7.2828 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3418 -7.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0547 -7.2775 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3449 -8.5176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0516 -6.4525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4582 -5.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6332 -5.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 11 1 1
12 13 1 0
2 3 1 0
6 7 2 0
1 3 1 0
13 14 1 0
14 15 1 0
15 12 1 0
1 8 1 1
7 8 1 0
2 16 1 6
16 17 1 0
8 9 2 0
17 18 1 0
9 4 1 0
18 19 1 0
4 5 2 0
19 20 1 0
4 10 1 0
19 21 2 0
2 1 1 0
20 22 1 0
23 22 1 0
24 23 1 0
22 24 1 0
10 11 1 0
5 6 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.42Molecular Weight (Monoisotopic): 331.1896AlogP: 2.20#Rotatable Bonds: 8Polar Surface Area: 72.48Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.79CX LogP: 1.05CX LogD: -1.28Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -0.06
References 1. Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP.. (2012) Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile., 55 (2): [PMID:22171543 ] [10.1021/jm201157c ]